| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.08▼ | 2.09▼ | 2.10▼ | 2.10▼ | 2.17▼ |
| MA10 | 2.08▲ | 2.10▼ | 2.10▼ | 2.12▼ | 2.20▼ |
| MA20 | 2.09▼ | 2.10▼ | 2.09▼ | 2.18▼ | 2.11▼ |
| MA50 | 2.11▼ | 2.09▼ | 2.12▼ | 2.23▼ | 5.70▼ |
| MA100 | 2.10▼ | 2.12▼ | 2.18▼ | 2.08▼ | 14.04▼ |
| MA200 | 2.09▼ | 2.19▼ | 2.21▼ | 2.24▼ | 21.74▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | -0.004▼ | 0.002▲ | -0.015▼ | 0.359▲ |
| RSI | 42.548▼ | 44.393▼ | 43.489▼ | 42.686▼ | 37.021▼ |
| STOCH | 63.095 | 24.364 | 54.623 | 15.948▼ | 34.737 |
| WILL %R | -60.000 | -75.000▼ | -75.000▼ | -88.889▼ | -65.979 |
| CCI | -22.222 | -107.937▼ | -48.898 | -76.619 | -38.933 |
|
Wednesday, August 13, 2025 09:30 PM
Following positive preclinical data, simufilam development to advance with a clinical study expected to begin in H1 2026 for the potential treatment of TSC-related epilepsy Recent appointment of ...
|
|
Tuesday, August 12, 2025 10:59 PM
Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now Real-time streaming data can be valuable ...
|
|
Thursday, August 07, 2025 05:56 AM
(RTTNews) - Biotechnology company Cassava Sciences, Inc. (SAVA) announced Thursday the appointment of Joseph Hulihan as Chief Medical Officer (CMO). Hulihan will devote approximately half of his ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/09/25 | 2.10 | 2.16 | 2.06 | 2.08 | 601,600 |
| 16/09/25 | 2.08 | 2.10 | 2.06 | 2.09 | 316,761 |
| 15/09/25 | 2.12 | 2.1383 | 2.04 | 2.08 | 592,061 |
| 12/09/25 | 2.15 | 2.16 | 2.09 | 2.11 | 511,072 |
| 11/09/25 | 2.10 | 2.186 | 2.10 | 2.16 | 478,800 |
| 10/09/25 | 2.15 | 2.17 | 2.10 | 2.10 | 523,300 |
| 09/09/25 | 2.14 | 2.20 | 2.13 | 2.18 | 400,866 |
| 08/09/25 | 2.17 | 2.19 | 2.12 | 2.14 | 405,400 |
| 05/09/25 | 2.14 | 2.19 | 2.13 | 2.16 | 317,800 |
| 04/09/25 | 2.21 | 2.22 | 2.12 | 2.15 | 485,900 |
|
|
||||
|
|
||||
|
|